Patents Assigned to Actinium Pharmaceuticals, Limited
  • Patent number: 6403771
    Abstract: The present invention relates to the field of site directed therapy. More specifically the invention relates to site directed radio therapy, and provides a method for production of radioconjugates and an apparatus for radioimmunotherapy. The method, conjugates and apparatus can be practicalized without the need for radioactive shielding and/or airtight facilities. Without these restrictions the invention provides a simple and efficient means of therapy at the bed-side of the patient.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: June 11, 2002
    Assignee: Actinium Pharmaceuticals, Limited
    Inventor: Maurits W. Geerlings